FdaApplication
NDA 219301
Identifiers
- fda_app_no: NDA219301
Properties
| Property | Value |
|---|---|
| applicant_name | KALVISTA PHARMACEUTICALS LTD |
| application_type | NDA |
| approval_date | 2025-07-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EKTERLY | SEBETRALSTAT | 300MG | TABLET;ORAL |
1 product